GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Filament Health Corp (OTCPK:FLHLF) » Definitions » Capex-to-Operating-Income

FLHLF (Filament Health) Capex-to-Operating-Income : 0.00 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Filament Health Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Filament Health's Capital Expenditure for the three months ended in Sep. 2024 was $-0.01 Mil. Its Operating Income for the three months ended in Sep. 2024 was $-0.66 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Filament Health Capex-to-Operating-Income Historical Data

The historical data trend for Filament Health's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Filament Health Capex-to-Operating-Income Chart

Filament Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
- - - -

Filament Health Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Filament Health's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Filament Health's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Filament Health's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Filament Health's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Filament Health's Capex-to-Operating-Income falls into.



Filament Health Capex-to-Operating-Income Calculation

Filament Health's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.043) / -3.667
=N/A

Filament Health's Capex-to-Operating-Income for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.008) / -0.664
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Filament Health  (OTCPK:FLHLF) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Filament Health Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Filament Health's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Filament Health Business Description

Traded in Other Exchanges
Address
4475 Wayburne Drive, Unit 210, Burnaby, BC, CAN, V5G 4X4
Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.

Filament Health Headlines